|
HN1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65856217648752E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.0460971219054E-11 |
| Normal-vs-Stage2 |
3.47560000002467E-07 |
| Normal-vs-Stage3 |
8.44735392746543E-12 |
| Normal-vs-Stage4 |
5.74984504453369E-12 |
| Stage1-vs-Stage2 |
8.337000E-01 |
| Stage1-vs-Stage3 |
1.723790E-01 |
| Stage1-vs-Stage4 |
6.058900E-03 |
| Stage2-vs-Stage3 |
4.450400E-01 |
| Stage2-vs-Stage4 |
8.097500E-02 |
| Stage3-vs-Stage4 |
1.963410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68893804392201E-12 |
| Normal-vs-AfricanAmerican |
4.48100000000062E-05 |
| Normal-vs-Asian |
4.04119999686259E-08 |
| Caucasian-vs-AfricanAmerican |
9.968600E-01 |
| Caucasian-vs-Asian |
8.696600E-01 |
| AfricanAmerican-vs-Asian |
9.253200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.84570034203568E-10 |
| Normal-vs-Female |
1.70119474063313E-12 |
| Male-vs-Female |
7.534600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.9339997098532E-10 |
| Normal-vs-Age(41-60Yrs) |
7.18725079451588E-12 |
| Normal-vs-Age(61-80Yrs) |
1.99530392208658E-11 |
| Normal-vs-Age(81-100Yrs) |
6.119900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.032800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.932000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.898000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.352400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.989600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.339200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.342400E-01 |
| Classical-VS-Follicular |
5.608800E-01 |
| Classical-VS-Other |
8.892800E-01 |
| Classical-VS-Normal |
3.64130947616559E-12 |
| Tall-VS-Follicular |
4.290800E-01 |
| Tall-VS-Other |
7.559400E-01 |
| Tall-VS-Normal |
8.94370000281697E-09 |
| Follicular-VS-Other |
9.608400E-01 |
| Follicular-VS-Normal |
8.92810003705335E-09 |
| Other-VS-Normal |
1.274190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.08704189883247E-13 |
| Normal-vs-N1 |
1.39880329541597E-11 |
| N0-vs-N1 |
3.774000E-02 |
|
|
